{
  "id": "1a8d00e1-99a7-4013-8b4e-1bd56cdb6563",
  "answer": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has a balanced company news read. Its latest completed weekly trend is negative.",
  "status": "balanced",
  "as_of": "2026-08-16T01:26:29.196563+00:00",
  "period_end": "2026-08-07",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "SES:T14",
    "name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14)",
    "identity": {
      "sharemaestro_id": "4d9b68dd-fd4b-44bf-87ad-12b59e08e622",
      "canonical_name": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "T14"
      ],
      "provider_symbols": {
        "eodhd": [
          "T14.SG"
        ],
        "yahoo": "T14.SI",
        "market": "SES",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Singapore",
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Specialty & Generic"
  },
  "score": 52.0,
  "confidence": 24,
  "evidence_count": 10,
  "independent_sources": 3,
  "freshest_evidence": "2026-08-14T10:52:17+00:00",
  "previous_read": 52.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "T14",
    "company": "Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited",
    "country": "Singapore",
    "currency": "USD",
    "exchange": "SES",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "week_end": "2026-08-07",
    "asset_type": "equity",
    "news_count": 10,
    "trend_state": "negative",
    "latest_close": "2.750000",
    "score_change": 0.0,
    "weekly_change": -1.434,
    "evidence_status": "provisional",
    "sentiment_score": 52
  },
  "canonical_url": "https://sharemaestro.com/evidence/1a8d00e1-99a7-4013-8b4e-1bd56cdb6563/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/4d9b68dd-fd4b-44bf-87ad-12b59e08e622/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=T14"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "a7920b1677d209cf6c6694548a4d841d856795ae0f69100b02a63bdacd43b46a",
  "citation": "Sharemaestro, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14), 2026-08-16, https://sharemaestro.com/evidence/1a8d00e1-99a7-4013-8b4e-1bd56cdb6563/"
}